Literature DB >> 17292065

A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.

Esther H Lim1, Narasimhan Danthi, Mark Bednarski, King C P Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 17292065     DOI： 10.1016/j.nano.2005.03.008

Source DB:  PubMed          Journal:  Nanomedicine        ISSN： 1549-9634            Impact factor:   5.307


× No keyword cloud information.
  14 in total

1.  Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors.

Authors:  Garry K Seward; Yubin Bai; Najat S Khan; Ivan J Dmochowski
Journal:  Chem Sci       Date:  2011-06       Impact factor: 9.825

2.  Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.

Authors:  Anirudh Sattiraju; Xiaobing Xiong; Darpan N Pandya; Thaddeus J Wadas; Ang Xuan; Yao Sun; Youngkyoo Jung; Kiran Kumar Solingapuram Sai; Jay F Dorsey; King C Li; Akiva Mintz
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

3.  Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Authors:  Irene Tsiapa; George Loudos; Eirini A Fragogeorgi; Penelope Bouziotis; Dimitrios Psimadas; Stavros Xanthopoulos; Maria Paravatou-Petsotas; Lazaros Palamaris; Alexandra D Varvarigou; Dimitris Karnabatidis; George C Kagadis
Journal:  Cancer Biother Radiopharm       Date:  2014-12       Impact factor: 3.099

Review 4.  Inorganic nanomaterials for tumor angiogenesis imaging.

Authors:  Zhuang Liu; Rui Peng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 5.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.

Authors:  Gustav J Strijkers; Ewelina Kluza; Geralda A F Van Tilborg; Daisy W J van der Schaft; Arjan W Griffioen; Willem J M Mulder; Klaas Nicolay
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

Review 6.  Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.

Authors:  Payaningal R Somanath; Nikolay L Malinin; Tatiana V Byzova
Journal:  Angiogenesis       Date:  2009-03-08       Impact factor: 9.596

Review 7.  Integrins in angiogenesis and lymphangiogenesis.

Authors:  Christie J Avraamides; Barbara Garmy-Susini; Judith A Varner
Journal:  Nat Rev Cancer       Date:  2008-05-22       Impact factor: 60.716

8.  Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.

Authors:  Tae Jin Kim; Charles N Landen; Yvonne G Lin; Lingegowda S Mangala; Chunhua Lu; Alpa M Nick; Rebecca L Stone; William M Merritt; Guillermo Armaiz-Pena; Nicholas B Jennings; Robert L Coleman; David A Tice; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

Review 9.  Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors.

Authors:  Xiaoyu Xu; Guanghui Yang; Honglu Zhang; Glenn D Prestwich
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-08-12       Impact factor: 3.072

10.  Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

Authors:  Yang Zhou; Sudipta Chakraborty; Shuang Liu
Journal:  Theranostics       Date:  2011-01-18       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.